News

News

  • September 27, 2016

    IDIBAPS researchers identify a new therapeutic target for liver cancer

    IDIBAPS researchers have identified the first epi-driver in liver cancer, a type of epigenetic alteration in the IGF2 gene that causes tumors to grow. In the study, published in the Gastroenterology journal, they have found that this alteration occurs in 15% of tumors and that a monoclonal antibody can effectively block it and slow tumor progression in animal models. Dr. Josep M. Llovet, ICREA Professor, Head of the Translational research in hepatic oncology IDIBAPS group and Director of the Mount Sinai Liver Cancer Program at Icahn School of Medicine at Mount Sinai (New York), has coordinated this study. The first authors of the article are Iris Martínez-Quetglas and Roser Pinyol, researchers at the same team.

    Read the rest of this entry

  • September 26, 2016

    Dr. Àlvar Agustí, chairman of the GOLD initiative for the diagnosis and treatment of COPD

    Dr. Alvar Agustí, has been elected president of the Global Initiative for Chronic Obstructive Lung Disesase (GOLD) a global consensus about the strategy for the diagnosis, treatment and prevention of Chronic Obstructive Pulmonary Disease (COPD). Dr. Agustí is Director of the Institute Clínic Respiratory at Hospital Clínic de Barcelona, Head of the Inflammation and repair in respiratory illnesses IDIBAPS team, member of the Networked Biomedical Research Center for Respiratory Diseases (CIBERES) and president and founder of the Barcelona Respiratory Network (BRN).

    Read the rest of this entry

  • September 19, 2016

    Josep Brugada, doctor honoris causa by Tucumán University

    Dr. Josep Brugada has been awarded the title of doctor honoris causa by the Universidad Nacional de Tucumán (Argentina) in recognition of his medical and research career. Dr. Brugada is cardiologist at the Hospital Clínic and head of the research team of the IDIBAPS "Arrhythmias, Resynchronization and cardiac imaging ".

    Read the rest of this entry

  • September 16, 2016

    IDIBAPS shares one milion euros to develop a project on Multiple Sclerosis

    Neuroscientist Elena H. Martínez-Lapiscina, researcher of the IDIBAPS, shares with other XXXX experts a million euros that the Grant for Multiple Sclerosis Innovation (GMSI) award to the best translational research projects which contribute to increase or improve the knowledge on Multiple Sclerosis ( MS) and the development of new therapies. Dr. Elena H. Martínez-Lapiscina project, presented at the ECTRIMS congress (European Comitee for Treatment and Research in Multiple Sclerosis ), aims to give a boost to the understanding of the disease and the developement of therapies through the analysis of the retina of affected patients.

    Read the rest of this entry

  • September 16, 2016

    Premiere of the film "Brain on Fire" at the Toronto International Film Festival

    The Brain on Fire film will be released today at the Toronto International Film Festival. It is based on the eponymous bestseller written by Susannah Cahalan, in which she explains her recovery after an autoimmune disorder that initially seemed a psychosis. It was an anti-NMDAR encephalitis, a disease discovered by Dr. Josep Dalmau, ICREA professor at IDIBAPS and consultant at the Neurology Department of Hospital Clínic, together with researchers from the University of Pennsylvania.

    Read the rest of this entry

PreviousNext